OrthoPediatrics Corp.
$16.65
▼
-1.41%
2026-04-21 07:43:01
www.orthopediatrics.com
NGM: KIDS
Explore OrthoPediatrics Corp. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$420.89 M
Current Price
$16.65
52W High / Low
$23.7 / $14.91
Stock P/E
—
Book Value
$13.81
Dividend Yield
—
ROCE
-6.27%
ROE
-11.31%
Face Value
—
EPS
$-1.69
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
602
Beta
1.16
Debt / Equity
32.31
Current Ratio
5.55
Quick Ratio
2.65
Forward P/E
-22.98
Price / Sales
1.71
Enterprise Value
$454.83 M
EV / EBITDA
-57.72
EV / Revenue
1.92
Rating
None
Target Price
$24.89
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Orthofix Medical Inc. | $12.65 | — | $507.83 M | — | -12.14% | -19.34% | $16.99 / $10.24 | $11.3 |
| 2. | Spectral AI, Inc. | $1.89 | — | $60.15 M | — | -1104.36% | 116.67% | $3.21 / $1.13 | $-0.19 |
| 3. | Perspective Therapeutics, Inc. | $4.55 | — | $478.52 M | — | -47.66% | -41.65% | $6.16 / $1.75 | $2.79 |
| 4. | Axogen, Inc. | $37.23 | — | $2 B | — | -3.96% | -13.49% | $39.99 / $9.22 | $2.73 |
| 5. | 908 Devices Inc. | $7.3 | 13.73 | $267.64 M | — | -16.46% | -25.77% | $9.34 / $4.2 | $3.96 |
| 6. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 7. | IceCure Medical Ltd | $0.36 | — | $24.87 M | — | -166.53% | -1.89% | $1.4 / $0.28 | $0.12 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 61.6 M | 61.25 M | 61.08 M | 52.41 M | 52.67 M | — |
| Operating Profit | -5.51 M | -4.87 M | -7.69 M | -10.94 M | -8.57 M | — |
| Net Profit | -10.1 M | -11.77 M | -7.11 M | -10.66 M | -16.07 M | — |
| EPS in Rs | -0.4 | -0.47 | -0.28 | -0.42 | -0.64 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 236.35 M | 204.73 M | 148.73 M | 122.29 M |
| Operating Profit | -29 M | -29.52 M | -25.77 M | -21.79 M |
| Net Profit | -39.65 M | -37.82 M | -20.97 M | 1.26 M |
| EPS in Rs | -1.57 | -1.5 | -0.83 | 0.05 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 508.63 M | 473.21 M | 438.75 M | 427.73 M |
| Total Liabilities | 162.03 M | 118.64 M | 61.72 M | 49.08 M |
| Equity | 346.6 M | 354.57 M | 377.02 M | 378.65 M |
| Current Assets | 256.42 M | 237.17 M | 226.5 M | 226.72 M |
| Current Liabilities | 46.2 M | 33.96 M | 41.67 M | 30.87 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -4.85 M | -27.05 M | -27.05 M | -21.77 M |
| Investing CF | -43.63 M | -13.16 M | 41.68 M | -113.37 M |
| Financing CF | 23.98 M | 53.13 M | 7.3 M | 135.97 M |
| Free CF | -15.96 M | -41.31 M | -43.92 M | -31.8 M |
| Capex | -11.11 M | -14.26 M | -16.88 M | -10.03 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 37.65% | 21.62% | — | — |
| Earnings Growth % | -80.33% | -1767.25% | — | — |
| Profit Margin % | -18.47% | -14.1% | 1.03% | — |
| Operating Margin % | -14.42% | -17.32% | -17.82% | — |
| Gross Margin % | 72.58% | 74.8% | 74.14% | — |
| EBITDA Margin % | -5.1% | -5.63% | -7.11% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.